A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155] |
O'Cearbhaill, Roisin |
|
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184] |
O'Cearbhaill, Roisin |
|
High-Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B-Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients
[Protocol 10-181] |
Noy, Ariela |
- AIDS-Associated Cancers
- AIDS-Associated Lymphomas
- Blood & Marrow Stem Cell Transplantation
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase II Study of Dose-Adjusted EPOCH Chemotherapy with or without Rituximab in Patients with Untreated Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, or Plasmablastic Lymphoma
[Protocol 13-022] |
Noy, Ariela |
|
A Study of Bortezomib plus (R)ICE in Subjects with Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma
[Protocol 09-063] |
Noy, Ariela |
- AIDS-Associated Cancers
- AIDS-Associated Lymphomas
- Lymphoma
|
A Phase I/II Study of EPOCH Chemotherapy, Bortezomib, and Raltegravir for the Treatment of HTLV-1-Associated T-Cell Leukemia/Lymphoma
[Protocol 12-146] |
Noy, Ariela |
|
A Phase I/II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin's Lymphoma
[Protocol 11-013] |
Noy, Ariela |
- AIDS-Associated Cancers
- Lymphoma
|
Prostate Cancer Treatment Decision-Making and Survivorship
[Protocol 11-058] |
Nelson, Christian |
- Prostate Cancer
- Localized Disease
- Quality of Life
- Survivorship
|
The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men with Prostate Cancer Age 65 and Older
[Protocol 06-084] |
Nelson, Christian |
- Geriatrics
- Prostate Cancer
- Localized Disease
- Quality of Life
- Rising PSA After Primary Therapy
- Psychiatry & Behavioral Sciences
- Survivorship
|
ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Phase II Study of Early Post-Operative Abdominal Chemotherapy versus Heated Abdominal Chemotherapy for Cancers of the Appendix, Colon, or Rectum that Have Spread to the Abdominal Lining
[Protocol 12-289] |
Nash, Garrett |
|
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of
Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
[Protocol 09-005] |
Mulhall, John |
- Prostate Cancer
- Survivorship
|
A Phase III Study of BMS-936558 Versus Everolimus in Patients with Advanced or Metastatic Renal Cell Carcinoma Who Received Prior Anti-Angiogenic Therapy
[Protocol 12-159] |
Motzer, Robert |
|
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162] |
Motzer, Robert |
|
A Phase II Study of Everolimus as Second-Line Therapy in the Treatment of Metastatic Renal Cell Carcinoma
[Protocol 11-197] |
Motzer, Robert |
|
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
[Protocol 12-282] |
Moskowitz, Craig |
|
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma
[Protocol 08-026] |
Moskowitz, Craig |
|
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007] |
Moskowitz, Alison |
|
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma
[Protocol 11-142] |
Moskowitz, Alison |
|
Radium-223 (Alpharadin) in Men with Castration-Resistant Prostate Cancer and Bone Metastases
[Protocol 12-199] |
Morris, Michael |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138] |
Morris, Michael |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
